AKT1 and synovial sarcoma: Combination therapy utilizing AKT and MEK inhibitors was able to phenocopy the effects of nintedanib, thereby confirming the importance of dual blockade of the AKT and ERK signaling as a means of inhibiting growth of SS and MPNST cells [118].